Enliven Therapeutics (NASDAQ:ELVN) Shares Down 2.2% Following Insider Selling

Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) were down 2.2% during mid-day trading on Tuesday after an insider sold shares in the company. The company traded as low as $14.18 and last traded at $14.52. Approximately 20,237 shares traded hands during trading, a decline of 85% from the average daily volume of […]

Leave a Reply

Your email address will not be published.

Previous post Associated Capital Group (NYSE:AC) Shares Down 2.1%
Next post 5 financial new year’s resolutions for 2024